nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Act Up, the heart of French AIDS activism
|
Marche, Guillaume |
|
|
20 |
7 |
p. 790-791 |
artikel |
2 |
Acute respiratory distress syndrome during a pandemic—an obvious diagnosis?
|
Reisinger, Alexander C |
|
|
20 |
7 |
p. 873 |
artikel |
3 |
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
|
|
|
|
20 |
7 |
p. 769-770 |
artikel |
4 |
Anita Zaidi
|
Kirby, Tony |
|
|
20 |
7 |
p. 789 |
artikel |
5 |
Authors' reply
|
Baud, David |
|
|
20 |
7 |
p. 775-776 |
artikel |
6 |
Balanced immunity is key for a successful dengue vaccine
|
Reyes-Sandoval, Arturo |
|
|
20 |
7 |
p. 761-762 |
artikel |
7 |
Cabotegravir, a new option for PrEP
|
Kirby, Tony |
|
|
20 |
7 |
p. 781 |
artikel |
8 |
Changes in M types of Streptococcus pyogenes in Chinese children with scarlet fever
|
Yu, Dingle |
|
|
20 |
7 |
p. 780 |
artikel |
9 |
Congenital syphilis, the great imitator—case report and review
|
Keuning, Maya W |
|
|
20 |
7 |
p. e173-e179 |
artikel |
10 |
Connecting clusters of COVID-19: an epidemiological and serological investigation
|
Yong, Sarah Ee Fang |
|
|
20 |
7 |
p. 809-815 |
artikel |
11 |
Correction to Lancet Infect Dis 2019; published online April 20. https://doi.org/10.1016/S1473-3099(20)30160-2
|
|
|
|
20 |
7 |
p. e148 |
artikel |
12 |
Correction to Lancet Infect Dis 2019; published online April 20. https://doi.org/10.1016/S1473-3099(20)30160-2
|
|
|
|
20 |
7 |
p. e148 |
artikel |
13 |
Correction to Lancet Infect Dis 2020; published online March 27. https://doi.org/10.1016/S1473-3099(20)30200-0
|
|
|
|
20 |
7 |
p. e148 |
artikel |
14 |
Correction to Lancet Infect Dis 2020; published online March 30. https://doi.org/10.1016/S1473-3099(20)30150-X
|
|
|
|
20 |
7 |
p. e148 |
artikel |
15 |
Correction to Lancet Infectious Diseases 2020; published online April 27. https://doi.org/10.1016/S1473-3099(20)30287-5
|
|
|
|
20 |
7 |
p. e148 |
artikel |
16 |
Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5
|
|
|
|
20 |
7 |
p. e148 |
artikel |
17 |
COVID-19 and medical education
|
Ahmed, Hanad |
|
|
20 |
7 |
p. 777-778 |
artikel |
18 |
COVID-19 in Iran: round 2
|
Venkatesan, Priya |
|
|
20 |
7 |
p. 784 |
artikel |
19 |
COVID-19: Playing away the pandemic
|
Balakrishnan, Vijay Shankar |
|
|
20 |
7 |
p. 792 |
artikel |
20 |
De-implementation strategy to reduce inappropriate use of intravenous and urinary catheters (RICAT): a multicentre, prospective, interrupted time-series and before and after study
|
Laan, Bart J |
|
|
20 |
7 |
p. 864-872 |
artikel |
21 |
Estimating case fatality rates of COVID-19
|
Spychalski, Piotr |
|
|
20 |
7 |
p. 774-775 |
artikel |
22 |
Estimating case fatality rates of COVID-19
|
Lipsitch, Marc |
|
|
20 |
7 |
p. 775 |
artikel |
23 |
Estimating case fatality rates of COVID-19
|
Kim, David Dongkyung |
|
|
20 |
7 |
p. 773-774 |
artikel |
24 |
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study
|
Zhang, Juanjuan |
|
|
20 |
7 |
p. 793-802 |
artikel |
25 |
From China: hope and lessons for COVID-19 control
|
Azman, Andrew S |
|
|
20 |
7 |
p. 756-757 |
artikel |
26 |
Global outbreak research: harmony not hegemony
|
|
|
|
20 |
7 |
p. 770-772 |
artikel |
27 |
Global shortage of personal protective equipment
|
Burki, Talha |
|
|
20 |
7 |
p. 785-786 |
artikel |
28 |
High COVID-19 testing rate in Portugal
|
Triunfol, Marcia |
|
|
20 |
7 |
p. 783 |
artikel |
29 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
20 |
7 |
p. 786 |
artikel |
30 |
Jacques Acar
|
Balakrishnan, Vijay Shankar |
|
|
20 |
7 |
p. 788 |
artikel |
31 |
Modelling COVID-19 transmission: from data to intervention
|
Jia, Zhongwei |
|
|
20 |
7 |
p. 757-758 |
artikel |
32 |
New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola
|
Thorson, Anna E |
|
|
20 |
7 |
p. 766-767 |
artikel |
33 |
Next-generation rotavirus vaccines: important progress but work still to be done
|
Bines, Julie E |
|
|
20 |
7 |
p. 762-764 |
artikel |
34 |
Political casualties of the COVID-19 pandemic
|
The Lancet Infectious Diseases, |
|
|
20 |
7 |
p. 755 |
artikel |
35 |
Pregnancy and breastfeeding in the context of Ebola: a systematic review
|
Foeller, Megan E |
|
|
20 |
7 |
p. e149-e158 |
artikel |
36 |
Real estimates of mortality following COVID-19 infection
|
Baud, David |
|
|
20 |
7 |
p. 773 |
artikel |
37 |
Refractory laryngeal papillomatosis requiring total laryngectomy
|
Nishida, Hayato |
|
|
20 |
7 |
p. 874 |
artikel |
38 |
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities
|
Darrow, Jonathan J |
|
|
20 |
7 |
p. e159-e164 |
artikel |
39 |
Research brief
|
Mohammadi, Dara |
|
|
20 |
7 |
p. 787 |
artikel |
40 |
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
|
Folegatti, Pedro M |
|
|
20 |
7 |
p. 816-826 |
artikel |
41 |
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
|
Koch, Till |
|
|
20 |
7 |
p. 827-838 |
artikel |
42 |
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial
|
Groome, Michelle J |
|
|
20 |
7 |
p. 851-863 |
artikel |
43 |
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
|
Kallas, Esper G |
|
|
20 |
7 |
p. 839-850 |
artikel |
44 |
Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis
|
Amoah, Abena S |
|
|
20 |
7 |
p. e165-e172 |
artikel |
45 |
Stigma during the COVID-19 pandemic
|
Bagcchi, Sanjeet |
|
|
20 |
7 |
p. 782 |
artikel |
46 |
The important role of serology for COVID-19 control
|
Winter, Amy K |
|
|
20 |
7 |
p. 758-759 |
artikel |
47 |
The INHALE trial: multiple reasons for a negative result
|
Rouby, Jean-Jacques |
|
|
20 |
7 |
p. 778-779 |
artikel |
48 |
The INHALE trial: multiple reasons for a negative result – Authors' reply
|
Niederman, Michael S |
|
|
20 |
7 |
p. 779-780 |
artikel |
49 |
The many estimates of the COVID-19 case fatality rate
|
Rajgor, Dimple D |
|
|
20 |
7 |
p. 776-777 |
artikel |
50 |
The UK hibernated pandemic influenza research portfolio: triggered for COVID-19
|
Simpson, Colin R |
|
|
20 |
7 |
p. 767-769 |
artikel |
51 |
Transforming use of two catheters: from accessory to hazard
|
Meddings, Jennifer |
|
|
20 |
7 |
p. 764-766 |
artikel |
52 |
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
|
Modjarrad, Kayvon |
|
|
20 |
7 |
p. 760-761 |
artikel |
53 |
Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China
|
Niehus, Rene |
|
|
20 |
7 |
p. 803-808 |
artikel |